title: Drug-drug interactions and drug resistance will limit access to treatment in patients with HIV and hepatitis C virus coinfection.
authors.forename: Michael
authors.initials: M
authors.lastname: Marks
authors.forename: Ranjababu
authors.initials: R
authors.lastname: Kulasegaram
mesh_terms: D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D005260:Female; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D011392:Proline / Q000031:analogs & derivatives*; D011480:Protease Inhibitors / Q000493:pharmacokinetics*
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011480:Protease Inhibitors; D011392:Proline